市場調查報告書
商品編碼
1305942
軟膠囊市場 - 按類型(明膠膠囊、素食膠囊)、按應用(處方藥、保健品和膳食補充劑)、按生產商(製藥、保健品),全球預測2023 - 2032年Softgel Capsules Market - By Type (Gelatin Based, Vegetarian Capsules), By Application (Prescription Medicines, Health & Dietary Supplements), By Manufacturer (Pharmaceutical, Nutraceutical), Global Forecast 2023 - 2032 |
到2032年,全球軟膠囊市場規模將急劇擴大。快速成長的老年人口及其對慢性疾病的易感性增加了對軟膠囊的需求。據世界衛生組織預測,到2040年,中國60歲以上人口將達到4.02億。此外,已開發經濟體和發展中經濟體蓬勃發展的醫療保健基礎設施將進一步為行業成長創造大量機會。同樣,2022年10月,美國農業部宣布投資約1.1億美元改善農村人口的醫療保健。
整個軟膠囊市場根據類型、應用、製造商和地區進行分類。
就類型而言,素食膠囊市場價值將在2022-2032年期間實現可觀成長。素食膠囊製造技術的不斷創新將促進該細分市場的成長。製造商探索素食膠囊的客製化和組合能力。這包括開發多腔或多層膠囊,允許在單粒膠囊中加入不同的成分或配方。這種客製化可實現精確給藥、聯合治療,並為患者提供更多便利。
在應用方面,2022年健康和膳食補充劑細分市場的行業規模達到58.5億美元。人們健康意識的提高增加了膳食補充劑的消費量。根據國際貿易管理局的資料,日本膳食補充劑行業價值94億美元,是全球第三大膳食補充劑行業。此外,全球各地政府為使這些補充劑價格合理而做出的努力也進一步促進了該細分市場的成長。
從生產商來看,製藥公司的行業價值將在2032年之前大幅成長。全球各地政府為擴大製藥行業而增加的投資對該細分市場的前景產生了積極影響。2023年3月,英國政府宣布向四家生命科學公司提供約2.77億英鎊(約3.01億美元)的政府和私人投資。此外,製藥公司大量供應各種軟膠囊將進一步促進該細分市場的成長。
從區域角度來看,2022年歐洲軟膠囊的市場佔有率超過33%。消費者對植物來源產品的支出增加,提高了該地區對素食軟膠囊的需求。此外,可支配收入的增加推動了消費者在營養保健品和膳食補充劑方面的支出,提高了產品的吸收率。該地區的成長還得益於蓬勃發展的醫療保健基礎設施和領先行業巨頭的強大影響力。
Global Softgel Capsules Market size will expand exponentially through 2032. Rapidly increasing geriatric population and its susceptibility to chronic disorders has increased the demand for softgel capsules. As per WHO, in China, the population of people above 60 years will reach 402 million by 2040. Moreover, the flourishing healthcare infrastructure in developed and developing economies will further create ample opportunities for industry growth. In the same direction, in October 2022, the USDA unveiled an investment of around USD 110 million to improve healthcare for rural people.
The overall softgel capsules market is divided based on type, application, manufacturer, and region.
Regarding the type, the vegetarian capsules market value will depict appreciable growth over 2022-2032. Growing innovations in the manufacturing technology of vegetarian capsules will contribute to segment growth. Manufacturers are exploring the customization and combination capabilities of vegetarian capsules. This involves the development of multi-chamber or multi-layer capsules that allow for the incorporation of different ingredients or formulations within a single capsule. This customization enables precise dosing, combination therapies, and improved patient convenience.
With respect to application, the industry size from the health & dietary supplements segment reached over USD 5.85 billion in 2022. Surging health consciousness among people has increased the consumption of dietary supplements. As per the International Trade Administration, Japan's dietary supplements industry, valued at USD 9.4 billion, is the third-largest dietary supplement industry in the world. Moreover, growing efforts by governments across the globe towards making these supplements affordable are further contributing to segment growth.
Based on the manufacturer, industry value from the pharmaceutical companies will amass significant gains through 2032. Rising investment by governments across the globe towards expanding the pharmaceutical sector is positively affecting segment outlook. In March 2023, the UK government announced a government and private investment of around £277 million (~USD 301 million) to four life science companies. Moreover, the high availability of a wide range of softgel capsules in pharmaceutical companies will further contribute to segment growth.
From a regional perspective, Europe softgel capsules market share was more than 33% in 2022. Rising consumer spending on plant-sourced products has increased the demand for vegan softgel capsules in the region. Moreover, surging disposable income has propelled consumer spending on nutraceuticals and dietary supplements, increasing product uptake. Regional growth can also be ascribed to the flourishing healthcare infrastructure and the strong presence of leading industry giants.